Oncologie

TAXOL (paclitaxel) safety in patients with platinum pretreated ovarian carcinoma : an interim analysis of a phase II multicenter study

Annals of Oncology 5 : S33-S38, 1994 Guastalla J-P, Lhommé C, Dauplat J, Namer M, Bonneterre J, Oberling F, Pouillart P, Fumoleau P, Kerbrat P, Tubiana N, Heron J-F, Bugat R, Fleury J, Ferrero J-M, Vennin P, Dufour P, Dieras V, Soler-Michel P, Pruvot I, Chanez M-A, Onetto N, Chazard M.

Vous souhaitez échanger
avec nos équipes

Contactez-nous

D’autres articles qui pourraient
vous intéresser

Risk Factors TFR CP-CML
Success stories - Oncologie - Facultatif

Identification of Individual Risk Factors for Treatment Free Remission (TFR) Failure in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients

Long-Term TKI Treatment Patterns
Success stories - Oncologie - Facultatif

Tyrosine Kinase Inhibitor (TKI) Treatment Patterns in 5,261 Chronic Phase (CP) Chronic Myeloid Leukemia (CML) Patients in “Real-Life”

Use of Digital Health Technology to Enable Drug Development
Oncologie

Use of Digital Health Technology to Enable Drug Development